A day in the life of a general manager at Bristol Myers Squibb
BMS’ Karen Costello talks about navigating change and challenges in the rapidly advancing biopharma sector. Karen Costello, the…
Bristol Myers Squibb Buys Out Cancer Cell Therapy Partner 2seventy Bio In $286M Deal
Bristol Myers Squibb is acquiring 2seventy bio, a deal that gives the pharmaceutical giant full control over the…
Bristol-Myers Squibb Stock: A Strong Buy Amid Oncology Success
This article was written by Follow With over two decades of dedicated experience in investment, Allka Research has…
Bristol Myers Squibb Tops Q4 Estimates
Bristol Myers Squibb reported strong fourth-quarter earnings but its outlook for 2025 failed to meet expectations. Biopharmaceutical giant…